|
|
||||||||
Departments of Medicine, Biochemistry and Pediatrics, Case Western Reserve University, Cleveland, Ohio 44106-4951; and Division of Clinical Physiology, Karolinska Hospital, S-171 76 Stockholm, Sweden
The use of
2H2O
in estimating gluconeogenesis' contribution to glucose production
(%GNG) was examined during progressive fasting in three groups of
healthy subjects. One group (n = 3)
ingested 2H2O
to a body water enrichment of
0.35% 5 h into the fast. %GNG was
determined at 2-h intervals from the ratio of the enrichments of the
hydrogens at C-5 and C-2 of blood glucose, assayed in
hexamethylenetetramine. %GNG increased from 40 ± 8% at 10 h to 93 ± 6% at 42 h. Another group ingested
2H2O
over 2.25 h, beginning at 11 h (n = 7)
and 19 h (n = 7) to achieve
0.5%
water enrichment. Enrichment in plasma water and at C-2 reached steady
state
1 h after completion of
2H2O
ingestion. The C-5-to-C-2 ratio reached steady state by the completion
of
2H2O
ingestion. %GNG was 54 ± 2% at 14 h and 64 ± 2% at 22 h. A 3-h
[6,6-2H2]glucose
infusion was also begun to estimate glucose production from enrichments
at C-6, again in hexamethylenetetramine. Glucose produced by
gluconeogenesis was 0.99 ± 0.06 mg · kg
1 · min
1
at both 14 and 22 h. In a third group
(n = 3) %GNG reached steady state
2 h after
2H2O
ingestion to only
0.25% enrichment. In conclusion, %GNG by 2 h
after
2H2O
ingestion and glucose production using
[6,6-2H2]glucose
infusion, begun together, can be determined from hydrogen enrichments
at blood glucose C-2, C-5, and C-6. %GNG increases gradually from the
postabsorptive state to 42 h of fasting, without apparent change in the
quantity of glucose produced by gluconeogenesis at 14 and 22 h.
deuterium oxide; glucose; glycogen; hexamethylenetetramine
This article has been cited by other articles:
![]() |
M. O. Weickert, C. v. Loeffelholz, M. Roden, V. Chandramouli, A. Brehm, P. Nowotny, M. A. Osterhoff, F. Isken, J. Spranger, B. R. Landau, et al. A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1078 - E1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Staehr, O. Hother-Nielsen, H. Beck-Nielsen, M. Roden, H. Stingl, J. J. Holst, P. K. Jones, V. Chandramouli, and B. R. Landau Hepatic autoregulation: response of glucose production and gluconeogenesis to increased glycogenolysis Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1265 - E1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Belloto, F. Diraison, A. Basset, G. Allain, P. Abdallah, and M. Beylot Determination of protein replacement rates by deuterated water: validation of underlying assumptions Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1340 - E1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Allick, S. N. van der Crabben, M. T. Ackermans, E. Endert, and H. P. Sauerwein Measurement of gluconeogenesis by deuterated water: the effect of equilibration time and fasting period Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1212 - E1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Bederman, D. A. Dufner, J. C. Alexander, and S. F. Previs Novel application of the "doubly labeled" water method: measuring CO2 production and the tissue-specific dynamics of lipid and protein in vivo Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E1048 - E1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Sumida, J. H. Urdiales, and C. M. Donovan Impact of flow rate on lactate uptake and gluconeogenesis in glucagon-stimulated perfused livers Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E185 - E191. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Burgess, F. M. H. Jeffrey, C. Storey, A. Milde, N. Hausler, M. E. Merritt, H. Mulder, C. Holm, A. D. Sherry, and C. R. Malloy Effect of murine strain on metabolic pathways of glucose production after brief or prolonged fasting Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E53 - E61. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. van Thien, G. J. Weverling, M. T. Ackermans, N. canh Hung, E. Endert, P. A. Kager, and H. P. Sauerwein FFAs are not involved in regulation of gluconeogenesis and glycogenolysis in adults with uncomplicated P. falciparum malaria Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E609 - E615. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Basu, W. F. Schwenk, and R. A. Rizza Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Z. Brunengraber, B. J. McCabe, T. Kasumov, J. C. Alexander, V. Chandramouli, and S. F. Previs Influence of diet on the modeling of adipose tissue triglycerides during growth Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E917 - E925. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Katanik, B. J. McCabe, D. Z. Brunengraber, V. Chandramouli, F. J. Nishiyama, V. E. Anderson, and S. F. Previs Measuring gluconeogenesis using a low dose of 2H2O: advantage of isotope fractionation during gas chromatography Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E1043 - E1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boden, P. Cheung, T. P. Stein, K. Kresge, and M. Mozzoli FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E12 - E19. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |